Skip to main content
OpenTrials
Completed

NCT Number: NCT05118659

Mulligan Therapy Effects In Healthy Subjects With Induced Vertigo

This analysis aims to evaluate the immediate effect that cervical sustained natural apophyseal glides (SNAGs) have on a group of individuals with induced vertigo by a caloric vestibular stimulation.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Vertigo Ear Diseases Labyrinth Diseases Nervous System Diseases Neurologic Manifestations Otorhinolaryngologic Diseases Pathological Conditions, Signs and Symptoms Signs and Symptoms Vestibular Diseases

Age range

18 year–44 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

CSEU La Salle, Madrid, Spain

Loading trial locations.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Healthy subjects,
  • Age 18-44 years.

Exclusion criteria

  • Consume of antipsychotics, antidepressants, antiarrythmics and/or anticonvulsivants
  • Hippoacusia
  • Auditory diseases
  • Peripheral or central vestibulopathies
  • Cerviogenic dizziness
  • Balance disorders
  • Nistagmus
  • Oculomotor nerve dysfunctions
  • Migraine
  • Cervical osteoporosis, lashing or fracture
  • Discal cervical hernia
  • Cervical neuropathy
  • Psychriatic disorders
  • Epilepsy
  • Pregnancy

Treatment and study plan

sustained natural apophyseal glides

Procedure

It consists on a sustained apophyseal glides in a postero-anterior direction on C2 with a dose of three series of ten repetitions each

Other names: SNAG

SHAM SNAG

Procedure

Subjects on SNAG group received a simulation of the contact used for the SNAGs, without any vertebral glide, and with an active cervical extension

Primary outcomes

  1. vHIT (Video Head Impulse Test)

    Time frame: 15 minutes

    Detection of peripheral vestibular deficits and their recovery

Secondary outcomes

  1. Anxiety

    Time frame: 5 minutes

    state-trait anxiety was measured at the beginning of the study using the Spanish version of the trait-state anxiety inventory (STAI)

Sponsors and collaborators

Lead sponsor

Centro Universitario La Salle

Other

Registry information

Official study title

Mulligan Therapy Effects In Healthy Subjects With Induced Vertigo. A Randomized And Controlled Clinic Study

Important dates

Study start
2018
Primary completion
2018
Study completion
2018
First posted
Nov 12, 2021
Registry last updated
Nov 12, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.